Publications & References

Media

MedPage Today: Using the Skin Microbiome to Control Atopic Dermatitis [Read More]
  1. Nakatsuji, T., Chen, T. H., Narala, S., Chun, K. A., Two, A. M., Yun, T., … & Gallo, R. L. (2017). Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Science Translational Medicine, 9(378). [Read More]
  2. Nakatsuji, T., & Gallo, R. L. (2019). The role of the skin microbiome in atopic dermatitis. Annals of Allergy, Asthma & Immunology, 122(3), 263-269. [Read More]
  3. Nakatsuji, T., Hata, T. R., Tong, Y., Cheng, J. Y., Shafiq, F., Butcher, A. M., … & Gallo, R. L. (2021). Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial. Nature Medicine, 1-10. [Read More]
  4. Nakatsuji T., Gallo R.L., Shafiq F., Tong Y., Chun K., Butcher A.M., … Hata TR (2021). Use of Autologous Bacteriotherapy to Treat Staphylococcus aureus in Patients With Atopic Dermatitis: A Randomized Double- blind Clinical Trial. JAMA Dermatology 157(8)978-982 [Read More]
  5. Williams, M.R., Cau, L., Wang, Y., Kaul, D., Sanford, J.A.,…..Gallo, R.L. (2020). Interplay of Staphylococcal and Host Proteases Promotes Skin Barrier Disruption in Netherton Syndrome. Cell Reports, 30(9):2923-2933. [Read More]
  6. O’Neill, A. M., & Gallo, R. L. (2018). Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris. Microbiome, 6(1), 1-16. [Read More]
  7. Yamasaki, K., & Gallo, R. L. (2011, December). Rosacea as a disease of cathelicidins and skin innate immunity. In Journal of Investigative Dermatology Symposium Proceedings (Vol. 15, No. 1, pp. 12-15). Elsevier. [Read More]
  8. Yamasaki, K., Di Nardo, A., Bardan, A., Murakami, M., Ohtake, T., Coda, A., … & Gallo, R. L. (2007). Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nature Medicine, 13(8), 975-980. [Read More]